Blood thinning medications are prescribed for a very important reason; in some patients they can prevent serious health problems, and even death, caused by blood clots. For many years, a drug called Warfarin- marketed under the brand name Coumadin – was used very successfully to treat these patients.

The big downside of taking Warfarin, to many, was the fact that they had to be constantly monitored, being tested once every one to two weeks, to ensure the medication was still working and it was being taken at the right dosage. It was this careful monitoring, in part, that has made Warfarin one of the most medically successful drugs of the last fifty years or so.

In recent years, however, a new class of drugs came along that were designed to decrease the need for monitoring. These drugs include Xarelto, a drug produced by pharmaceutical giant Johnson & Johnson.

One of the other problems that anyone taking a blood thinner could suffer from is the risk of excessive bleeding. For those taking Warfarin, there is an ‘antidote’ that can help. Should excessive bleeding occur medical professionals can administer large doses of Vitamin K or introduce blood plasma products to help thicken the blood temporarily so that the bleeding stops.

This however, is not effective in patients taking Xarelto and similar drugs. This puts them at increased risk for serious complications and even death from uncontrollable excess bleeding. And excess bleeding can occur very easily in patients on blood thinners. A simple scrape, one that would usually be considered harmless, can even be a problem. The fact that they are then taking a medication that does not allow for the standard remedy for excess bleeding to be implemented puts them at a very high risk indeed.

There are now studies on Xarelto use that indicate it may lead to other health complications as well, including the following:

  • Brain Hemorrhages
  • Abdominal Hemorrhaging
  • Epidural Hematoma
  • External Bleeding
  • Gastrointestinal Hemorrhage
  • Internal Bleeding
  • Intracranial Hemorrhage
  • Kidney Failure
  • Liver Damage
  • Retinal Hemorrhage
  • Stroke
  • Death

The FDA and Xarelto

It was, of course, the FDA who approved Xarelto and thus far there has not been a recall of the medication. The agency is watching it very carefully though, because of the alarming number of studies documenting the serious possible side effects of the medication. In fact,  the FDA sent a warning letter to Johnson & Johnson in 2013 stating that a print ad the company was running was highly misleading, as it played down the risks and played up the benefits, namely the decreased need for testing.

In 2014 the FDA followed up this action by issueing a warning stating that people who suddenly stop taking the drug could be at risk for blood clots. Their investigation into Xarelto and other drugs like it is still currently ongoing.

Should You File a Xarelto Lawsuit?

It is to us, the attorneys at Baron & Budd, and to many others, obvious that Johnson & Johnson, or its actual manufacturer, Bayer, did not do their proper duty to patients. They failed to adequately warn patients of the risks that Xarelto presents or the fact that it, unlike Warfarin, does not respond to the standard ‘antidote’ to excessive bleeding. Therefore, it is our position that these companies be held liable for the impact their lack of car has had on patients who took Xarelto and experienced the serious side effects it can cause.

If you or a loved one have been affected by the side effects that can potentially come along with taking Xarelto, we may be able to help you get the compensation for your pain and suffering you deserve. To learn more simply complete our online contact form or call us toll-free at phone Number.

  • Get Answers Now

    Get a free case evaluation to help determine your legal rights.

  • Receive emails from Baron & Budd?
  • Receive text messages from Baron & Budd?
  • This field is for validation purposes and should be left unchanged.